FDA Offers Gene Therapy Advice on Hemophilia, Other Diseases

July 18, 2018

The Food and Drug Administration (FDA) explained the best ways gene therapy developers can get products to treat hemophilia, retinal disorders, and rare diseases approved to go on the market in new draft guidance documents it released on July 11.